Moreover, the analyses reveal significant difference between HAX1 levels in primary tumor samples between nonmetastatic and metastatic groups of patients, indicating that HAX1 may represent an independent risk factor for breast cancer metastasis. This evidence concerns the gene HAX1 and breast carcinoma.